Michael S. Kinch

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ.

VasGene Therapeutics, Inc. developed therapeutics based on vascular biology. Its products included target signal transduction pathways common to cancer cells and endothelial cells, resulting in anti-cancer agents with multiple modes of action and inhibition of tumor cell growth, anti-angiogenesis and prevention of tumor cell metastasis. The company was founded by Raymond A. Mirra Jr. and Parkash Gill in 1999 and was headquartered in Oak Park, CA.

Functional Genetics, Inc. operated as a biotechnology company. Its products facilitate simultaneous targeting of multiple co-morbid pathogens with a single drug. The company provided antiviral drugs that demonstrate beneficial activity against various viruses, included HIV, RSV, influenza, hepatitis viruses, herpes and bio-threat pathogens. Functional Genetics was founded in 1987 and was headquartered in Palo Alto, CA.